Medcura Overview
- Founded
-
2007

- Status
-
Private
- Employees
-
19

- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$7.5M
- Investors
-
13
Medcura General Information
Description
Developer of wound care platform designed to be used across a broad spectrum of clinical and non-clinical setups for managing many high-impact surgical bleeds. The company's platform transforms highly abundant natural materials into advanced wound treatment and hemostatic products for surgical, military, and consumer applications, it develops Rapid-Seal, antibacterial barriers and a robust and diverse range of products that innovatively control bleeding, enabling doctors to improve bleeding management while creating antibacterial barriers and enhancing healing environments.
Contact Information
- 5650 Rivertech Court
- Suite S
- Riverdale, MD 20737
- United States
Medcura Timeline
Medcura Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
14. Later Stage VC (Series A1) | 08-Sep-2022 | $7.5M | 000.00 | 000.00 | Completed | Generating Revenue |
13. Secondary Transaction - Private | 000.00 | Completed | Generating Revenue | |||
12. Secondary Transaction - Private | 01-Jun-2022 | 000.00 | Completed | Generating Revenue | ||
11. Later Stage VC | 01-Nov-2021 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
10. Later Stage VC (Series A) | 12-Aug-2021 | 00.00 | 0000 | 000.00 | Completed | Generating Revenue |
9. Later Stage VC (Series A) | 21-Sep-2020 | 00.000 | 00.000 | 0000 | Completed | Generating Revenue |
8. Angel (individual) | 31-Dec-2018 | 00.000 | 00.000 | Completed | Generating Revenue | |
7. Grant | 01-Apr-2018 | 000 | 00.00 | Completed | Pre-Clinical Trials | |
6. Grant | 19-Feb-2018 | $1.4M | $3.1M | Completed | Generating Revenue | |
5. Seed Round | 13-Jul-2017 | $3.1M | $3.1M | 00.00 | Completed | Generating Revenue |
Medcura Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-1 | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 000 | |
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Seed | 6,199,999 | $0.001000 | $0.5 | $0.5 | 1x | $0.5 | 18.85% |
Medcura Comparisons
Industry
Financing
Details
Medcura Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
InSphero | Formerly VC-backed | Schlieren, Switzerland | 00 | 000.00 | 000000000 | 000.00 |
000000 0000000000 | Venture Capital-Backed | Vancouver, Canada | 00 | 000.00 | 000000 - 000 | 000.00 |
0000000 000000000 | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
00000 00000000000 | Venture Capital-Backed | Middleton, WI | 00 | 0000 | 0000000000 0 | 0000 |
00000 0000000000 0 | Formerly PE-Backed | White Plains, NY | 000 | 000.00 | 000000&0 | 000.00 |
Medcura Patents
Medcura Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220347341-A1 | Hydrophobically-modified biopolymer materials | Pending | 03-Oct-2019 | 000000000 | |
CA-3156813-A1 | Hydrophobically-modified biopolymer materials | Pending | 03-Oct-2019 | 000000000 | |
CA-3135980-A1 | System and method to reduce tissue or organ adhesion | Pending | 05-Mar-2019 | 0000000000 | |
EP-3934659-A1 | System and method to reduce tissue or organ adhesion | Pending | 05-Mar-2019 | 0000000000 | |
EP-3934659-A4 | System and method to reduce tissue or organ adhesion | Pending | 05-Mar-2019 | A61K31/722 |
Medcura Executive Team (9)
Medcura Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
James Buck | Medcura | Chief Executive Officer, President & Board Member | 000 0000 |
Larry Tiffany JD | Medcura | Co-Founder, Chief Operating Officer & Board Member | 000 0000 |
Matthew Dowling Ph.D | Medcura | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Medcura Signals
Medcura Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Ironwood Investment Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
Aubrey Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Delaware Crossing Investor Group | Angel Group | 000 0000 | 000000 0 | ||
New York Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
Sung Capital Partners | Family Office | Minority | 000 0000 | 000000 0 |